Study of the AL3810 in the Treatment of Advanced Solid Tumor

NCT03117101 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Lucitanib

Sponsor

Haihe Biopharma Co., Ltd.

Collaborators

[object Object]